tiprankstipranks
Phasebio Pharmaceuticals Inc (PHAS)
NASDAQ:PHAS

Phasebio Pharmaceuticals (PHAS) Balance Sheet

0 Followers

Phasebio Pharmaceuticals Balance Sheet

Phasebio Pharmaceuticals's total assets for Q were $22.17M, a decrease of -42.67% from the previous quarter. PHAS total liabilities were $139.56M for the fiscal quarter, a -1.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Assets
$ 60.54M$ 50.36M$ 82.49M$ 63.03M$ 14.10M
Total Liabilities
$ 153.57M$ 75.56M$ 22.52M$ 12.10M$ 111.52M
Total Equity Gross Minority
$ -93.03M$ -25.20M$ 59.98M$ 50.93M$ -97.42M
Total Capitalization
$ -91.67M$ -18.43M$ 72.30M$ 58.43M$ -94.79M
Preferred Stock Equity
-----
Capital Lease Obligations
$ 1.55M$ 1.94M$ 1.77M$ 0.00-
Currency in USD

Phasebio Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis